BioCentury
ARTICLE | Finance

IPO watch

Biotech IPO news from CellSeed in Japan, GenMark in U.S. and Neovacs in France

March 22, 2010 7:00 AM UTC

Three ex-U.S. companies had IPO-related news last week. One priced, while two others filed.

Regenerative medicine company CellSeed Inc. (JASDAQ:7776) priced on Japan's JASDAQ exchange. The company sold 1.5 million shares at ¥1,500, raising ¥2.3 billion ($24.8 million) and giving it a market cap of ¥8 billion ($87.5 million), according to Japanese IPO data aggregator Tokyo IPO...